Arena and Eisai say new lorcaserin Ph III data show statistically significant … – The Pharma Letter

Genetic Engineering News Arena and Eisai say new lorcaserin Ph III data show statistically significant ... The Pharma Letter Arena Pharmaceuticals (Nasdaq: ARNA) and marketing partner Japanese drug major Eisai demonstrate statistically significant weight loss in obese and ... Arena weight-loss drug caused heart trouble San Francisco Chronicle Arena Release Results of BLOOM-DM Trial on Lorcaserin eMaxHealth FDA Denied Weight Loss Drug May Be Beneficial to Diabetics HealthNews Drug Store News ?- Pharmaceutical Business Review ?- Genetic Engineering News all 96 news articles?? Read more »

FDA Denied Weight Loss Drug May Be Beneficial to Diabetics – HealthNews

Genetic Engineering News FDA Denied Weight Loss Drug May Be Beneficial to Diabetics HealthNews While the Food and Drug Administration (FDA) has yet to approve one of the three new weight-loss drugs on their agenda, one of the recently ... Arena, Eisai: Lorcaserin produced weight loss in Type 2 diabetics during trial Drug Store News Arena Reports Phase III Data to Help Address Nonapprovable Status of Weight .. Read more »

Reading food labels, combined with exercise, can lead to weight loss – Genetic Engineering News

Reading food labels, combined with exercise, can lead to weight loss Genetic Engineering News Previous research has focused on food marketing and behaviour but has not followed related weight loss over time in this middle-aged demographic group. .. Read more »